Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study☆
Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426068766?dgcid=rss_sd_all
Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426068766?dgcid=rss_sd_all
“Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study☆.” Annals of Oncology.
@article{article36098,
title = {Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426068766?dgcid=rss_sd_all}
}